[Myeloproliferative disorders]. 1977

S Shirakawa

UI MeSH Term Description Entries
D009196 Myeloproliferative Disorders Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE. Disorder, Myeloproliferative,Disorders, Myeloproliferative,Myeloproliferative Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Shirakawa
September 2008, Blood,
S Shirakawa
February 1972, Medizinische Klinik,
S Shirakawa
August 1963, Archivos medicos panamenos,
S Shirakawa
September 2001, Best practice & research. Clinical haematology,
S Shirakawa
December 1990, Clinics in laboratory medicine,
S Shirakawa
December 2017, Hematology/oncology clinics of North America,
S Shirakawa
August 2014, Emergency medicine clinics of North America,
S Shirakawa
November 1985, Clinics in geriatric medicine,
S Shirakawa
February 2004, Therapeutische Umschau. Revue therapeutique,
S Shirakawa
January 2005, Clinical medicine (London, England),
Copied contents to your clipboard!